Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
January 25, 2022
Patent Application Number
16615115
Date Filed
May 4, 2018
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided are methods and compositions for treating myeloproliferative neoplasms patients carrying an IDH2 mutation and a JAK2 mutation.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
